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Human immunodeficiency virus type 1 (HIV-1) is considered to infect nondividing cells because nuclear localization signals
(NLS) in matrix (MA, p17Gag) and Vpr allow active nuclear transport of the preintegration complex. Previous studies
demonstrated that HIV-1 reverse transcription is successful only in cells with proliferative potential, thus restricting HIV-1
replication to cycling cells. To sort out this apparent discrepancy we compared the phenotype of a chimeric HIV-1 variant
lacking a functional Vpr and MA-NLS (R7.DVpr.DNLS), and previously described to lack replicative capacity in macrophages
and growth-arrested cells, with a chimera lacking a functional Vpr (R7.DVpr). Both variants replicated efficiently in primary
macrophages, with only minimal differences in the kinetics of reverse transcription, integration, or p24 production. In
agreement with our previous observation, elongation of reverse transcription was restricted to the proliferating subpopu-
lation of macrophages. Replication of R7.DVpr and R7.DVpr.DNLS could also be demonstrated in aphidicolin-treated macro-
phages, indicating efficient nuclear transport in G1/S phase-arrested cells. In conclusion, our results confirm the dependency
of the process of HIV-1 reverse transcriptase on cell proliferation in primary macrophages and exclude an important role of
MA-NLS and Vpr in macrophage infection. © 1999 Academic PressKey Words: HIV-1; macrophages; matrix-NLS; Vpr.
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GINTRODUCTION
Since macrophages are considered nondividing
ells, the capacity of lentiviruses such as HIV-1 to
nfect these cells has been attributed to specific fea-
ures of this virus group. The critical step was found to
e the nuclear import of the proviral genome mediated
y viral protein R (Vpr) and nuclear localization signal
NLS) in the matrix (MA) protein of gag (Bukrinsky et
l., 1992, 1993; Li et al., 1993). The HIV-1 preintegration
omplex docks at the nuclear pore through binding of
A-NLS to a protein of the karyopherin-a family (Gal-
ay et al., 1996). Recently it has been demonstrated
hat Vpr associates with karyopherin-a and therefore
nhances the affinity for MA-NLS binding and governs
uclear transport (Popov et al., 1998). Due to the ab-
ence of these signals in retroviruses, such as murine
eukemia virus, nuclear import of this virus was estab-
ished only after permeabilization of the nuclear mem-
rane, which occurs during mitosis (Roe et al., 1993;
armus and Swanstrom, 1985; Miller et al., 1990). A
utant HIV-1 variant that lacked a functional Vpr and
A-NLS of gag could not establish a productive infec-
ion in growth-arrested cells nor in primary macro-
1 To whom correspondence and reprint requests should be ad-
sressed. Fax: 31-20-5123310. E-mail: J_Schuitemaker@CLB.NL.
042-6822/99 $30.00
opyright © 1999 by Academic Press
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170hages (von Schwedler et al., 1994; Bukrinsky et al.,
992, 1993). The chimera with functional MA-NLS rep-
icated normally in growth-arrested cells and macro-
hages (Bukrinsky et al., 1993; von Schwedler et al., 1994).
hese studies failed to show, however, whether the chi-
eric HIV-1 lacking only a functional Vpr replicated in the
ondividing subpopulation of macrophages. Indeed, a sig-
ificant fraction of primary macrophages has proliferative
otential (Schmidtmayerova et al., 1997; Freed et al., 1997;
chuitemaker et al., 1994; Kootstra and Schuitemaker,
998). Several studies have now shown that HIV-1 replica-
ion in T cells, macrophages, and dendritic cells is depen-
ent on the cell cycle (Zack et al., 1992, 1990; Schuitemaker
t al., 1994; Kootstra and Schuitemaker, 1998; Blauvelt et al.,
997). The process of reverse transcription, which occurs
rior to nuclear transport, seems to be disturbed in noncyc-
ing cells (Zack et al., 1992, 1990; Schuitemaker et al., 1994;
ootstra and Schuitemaker, 1998). Our own studies have
hown that completion of proviral DNA synthesis was es-
ablished only in the macrophage subfraction that had tra-
ersed mitosis during inoculation (Schuitemaker et al.,
994; Kootstra and Schuitemaker, 1998). g-Irradiation, caus-
ng growth arrest in G1, but not aphidicolin treatment, ar-
esting cells in the G1/S phase of the cycle, interfered with
he establishment of a productive infection, suggesting that
ot mitosis but a cellular activation state coinciding with the
1/S phase of the cell cycle is required for reverse tran-cription.
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171HIV-1 MATRIX-NLS AND Vpr FUNCTION IN MACROPHAGESHere we analyzed whether the HIV-1 variant lacking a
unctional Vpr, which was previously reported to estab-
ish infection in nondividing cells (Bukrinsky et al., 1993;
on Schwedler et al., 1994), could indeed infect the mac-
ophage subfraction that lacked proliferative capacity. In
ddition, we compared the HIV-1 variant lacking a func-
ional Vpr and the HIV-1 variant lacking a functional
A-NLS and Vpr for their replicative capacity in macro-
hages in relation to the proliferative potential of the
ells.
RESULTS
fficient replication in primary macrophages of HIV-1
ariants lacking a functional MA-NLS and Vpr
We compared the replication kinetics of the chimeric
IV-1 variants R7.DVpr and R7.DVpr.DNLS in primary
DM. Five-day-cultured monocyte-derived macro-
hages (MDM) obtained from four different donors were
noculated with R7.DVpr or R7.DVpr.DNLS. MDM popula-
ions did not contain T lymphocytes, as demonstrated by
T–PCR with primers specific for CD2 (data not shown).
oth viruses replicated efficiently in MDM from all four
onors (Fig. 1). In three donors, the replication kinetics of
7.DVpr.DNLS were slightly delayed and impaired com-
FIG. 1. Replication kinetics of R7.DVpr (), and R7.DVpr.DNLS () in
DM were inoculated with an inoculum of 20 ng p24 antigen per 1 3
7.DVpr.DNLS. Virus replication was analyzed by measuring p24 produared to those of R7.DVpr. In one donor, p24 production wf R7.DVpr was somewhat impaired compared to
7.DVpr.DNLS, but showed similar kinetics (Fig. 1D).
longation of reverse transcription in primary
acrophages of R7.DVpr and R7.DVpr.DNLS
nly in the proliferating cell population
Previously, we demonstrated that HIV-1 replication, in
articular reverse transcription, in primary macrophages
as restricted to the cell fraction with proliferative ca-
acity (Schuitemaker et al., 1994; Kootstra and Schuite-
aker, 1998). Replication of R7.DVpr.DNLS is also re-
tricted to proliferating cells. Therefore, the absence of
eplication of R7.DVpr.DNLS in primary macrophages in
he study of Von Schwedler et al. would suggest that in
heir system no proliferating macrophages are present.
hus the normal replication of R7.DVpr in parallel cul-
ures of the same macrophages would indicate that this
ariant is able to replicate in proliferating as well as
onproliferating cells. If this were the case, we should
lso be able to detect at least elongated products of
everse transcription in the nonproliferating macrophage
raction infected with R7.DVpr. For comparison, the mac-
ophage-tropic HIV-1 variant Ba-L (Gartner et al., 1986)
as included in this experiment. Five-day-cultured MDM
y macrophages obtained from four different donors. Five-day-cultured
DM, corresponding to a virus titer of 1 3 104 TCID50 for R7.DVpr and
n the culture supernatant.primar
106 Mere exposed to DNase-treated inocula. During inocu-
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172 KOOTSTRA AND SCHUITEMAKERation macrophage proliferation was monitored by bro-
odeoxyuridine (BrdU) incorporation. Forty-eight hours
fter inoculation, cells were harvested and BrdU incor-
oration was visualized by a BrdU-specific monoclonal
ntibody and subsequent FACS analysis. Of the MDM,
% had traversed S phase and FACS sorting resulted in
97% pure BrdU-negative and a 59% pure BrdU-positive
ell fraction. BrdU-negative and BrdU-positive cell frac-
ions were mixed with HIV-1-negative peripheral blood
ononuclear cells (PBMC) to improve DNA isolation and
NA cell equivalents of 1 3 105 of the BrdU-negative and
3 104 of the BrdU-positive cell fractions were used for
CR analysis on the presence of proviral DNA. The
rocess of reverse transcription was analyzed by PCR
mplifying the LTR R/U5 region and the pol region, which
re early and intermediate products of reverse transcrip-
ion, respectively. To be able to distinguish newly syn-
hesized proviral DNA, MDM were treated with AZT for
0 min prior to inoculation. PCR analysis demonstrated
he absence of proviral DNA in the 39-azido-39-deoxythy-
idine (AZT)-treated cultures, indicating that all proviral
NA signals reflected newly synthesized proviral DNA
data not shown). In the BrdU-negative as well as the
rdU-positive MDM fractions the presence of proviral
NA corresponding to the R/U5 region could be demon-
trated, indicating efficient virus entry and initiation of
everse transcription irrespective the virus variant used
or inoculation (Fig. 2). The presence of proviral pol DNA
as restricted to the BrdU-positive proliferating cell frac-
ion, for both R7.DVpr and R7.DVpr.DNLS (Fig. 2).
rdU incorporation in macrophages reflects DNA
ynthesis during S phase of the cell cycle
One could argue that the incorporation of BrdU occurs
uring reverse transcription, thereby explaining the pres-
nce of proviral DNA only in the BrdU-positive fraction.
FIG. 2. PCR analysis for the presence of proviral DNA in the BrdU-
egative and BrdU-positive MDM fractions. To monitor reverse tran-
cription, a PCR amplifying the R/U5 fragment and a “nested” PCR
mplifying a conserved fragment of the pol gene representing, respec-
ively, an early and relatively late product in reverse transcription were
sed. Serial dilutions of 8E5 cells in uninfected PBMC were used for
IV-1 DNA standards.o exclude this, 5-day-differentiated MDM were exposed co BrdU. After 48 h the cells were fixed and BrdU incor-
oration was visualized using a monoclonal antibody
pecific for BrdU (Fig. 3A). The BrdU incorporation in
DM from different donors (n 5 35) varied between 2
nd 38%, with an average of 8.4% (n 5 35). In Figs. 3B
nd 3C, BrdU incorporation in MDM from two represen-
ative donors is shown. FACS analysis revealed that 11
nd 36%, respectively, of the MDM were BrdU-positive
Figs. 3B and 3C). g-Irradiation performed prior to the
ddition of BrdU completely blocked BrdU incorporation
Fig. 3B). HIV-1 inoculation of the MDM did not increase
he number of BrdU-positive MDM (Fig. 3C). These re-
ults indicate that BrdU incorporation reflects DNA syn-
hesis during S phase of the cell cycle rather than DNA
epair or proviral DNA synthesis.
eplication kinetics and reverse transcription of
7.DVpr and R7.DVpr.DNLS in relation to
acrophage proliferation
We next analyzed whether the somewhat impaired
eplication R7.DVpr.DNLS virus, as observed here in pri-
ary macrophages from some donors and reported as
ompletely without replication in other studies, could
epend on the potential and kinetics of proliferation of
arget cells. To this extent, the kinetics and magnitudes
f cell proliferation together with the replication kinetics
f wild-type and mutant viruses were studied in MDM
rom different donors (n 5 11). MDM were inoculated
ith Ba-L, R7.DVpr, and R7.DVpr.DNLS at day 5, 7, 9, 12, or
4. From parallel cultures, DNA was extracted 48 h after
noculation and subjected to PCR analysis for monitoring
irus entry, reverse transcription, and integration. To spe-
ifically detect integrated proviral DNA, a “nested” Alu
CR with primers specific for ubiquitous repeats found in
he human genome and HIV-1 was used. To be able to
istinguish newly synthesized proviral DNA, MDM were
reated with AZT for 30 min prior to inoculation. The
ZT-treated cultures revealed a positive signal for R/U5
roviral DNA, but all inocula were negative in the PCR
nalysis, implying that all proviral DNA signals reflected
ewly synthesized proviral DNA (Fig. 4B).
Virus replication as observed in MDM from three rep-
esentative donors with distinct proliferation kinetics is
hown in Fig. 4. MDM from donors A and B showed
igh-level proliferation above 1000 cpm per 105 MDM
rom days 5 to 7 and days 5 to 9, respectively, while
ow-level proliferation (,1000 cpm per 105 MDM) was
bserved during the subsequent days (Fig. 4). In con-
rast, MDM obtained from donor C showed a continuous
ow level of proliferation, reaching a maximum of 919
pm per 105 MDM at day 12. All three viruses replicated
ith the same kinetics and showed high levels of p24
roduction in MDM from all three donors when inocula-
ion was performed during the period in which maximum
ell proliferation could be measured. Inoculation of MDM
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173HIV-1 MATRIX-NLS AND Vpr FUNCTION IN MACROPHAGESrom donors A and B after the moment of maximum
roliferation resulted in a delayed or even completely
bsent replication for all three variants. In agreement,
CR analysis revealed less efficient reverse transcription
nd proviral integration in MDM inoculated after the
oment of maximum proliferation. In contrast, in MDM
rom donor C, R7.DVpr.DNLS replicated more rapidly
hen inoculation was performed at day 12 or 14 com-
ared to replication in MDM inoculated at day 5 to 10,
hile MDM proliferative capacity was already reduced at
ay 14. When compared to Ba-L and R7.DVpr, inoculation
rior to the moment of maximum proliferation resulted in
mpaired replication for R7.DVpr.DNLS in MDM from do-
or C. This impaired replication was not associated with
ifferences in the kinetics of reverse transcription or
roviral integration within 48 h after inoculation.
From DNA samples which were tested negative for
roviral DNA and which showed a decreased b-globin
ignal (days 9, 12, and 14 for donor A; days 12 and 14 for
FIG. 3. Analysis of macrophage proliferation by BrdU incorporation. F
ells were fixed and stained for BrdU incorporation. (A) Light microscopy
nd staining with AEC substrate. Poststaining was performed with Ma
DM (shaded curve) and MDM that were g-irradiated before the addit
DM (shaded curve) and MDM that were inoculated with HIV-1 Ba-Lonor B), an additional LTR R/U5 PCR analysis with a iNA input corrected for cell equivalents was performed.
n all cases PCR analysis resulted in a positive R/U5
ignal (data not shown), indicating that at least virus
ntry and initiation of reverse transcription had occurred.
fficient replication of HIV-1 variants lacking a
unctional MA-NLS and Vpr in growth-arrested
rimary macrophages
We demonstrated that the process of reverse tran-
cription is dependent on cell proliferation. Since this
roliferation-dependent step occurs prior to nuclear im-
ort, we cannot exclude the function of Vpr and the
A-NLS of gag in nuclear import. In a previous study we
howed that the actual process of mitosis is dispensable
or the establishment of a productive infection since
rowth arrest in G1/S phase did not interfere with HIV-1
eplication (Schuitemaker et al., 1994). To investigate
hether Vpr and the MA-NLS are essential for nuclear
y-cultured MDM were exposed to BrdU for 48 h and subsequently the
is of BrdU incorporation in MDM visualized by a HRP-labeled antibody
malum solution. (B) FACS analysis of BrdU incorporation in untreated
rdU (black line). (C) FACS analysis of BrdU incorporation in untreated
line).ive-da
analys
yer’s he
ion of Bmport, we compared the replication of R7.DVpr and
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175HIV-1 MATRIX-NLS AND Vpr FUNCTION IN MACROPHAGES7.DVpr.DNLS in growth-arrested primary macrophages.
herefore 5-day-cultured MDM were treated with aphidi-
olin (5 mg/ml) 24 h prior to inoculation with R7.DVpr and
7.DVpr.DNLS. Efficient replication for both viruses could
e detected in aphidicolin-treated MDM, although the
aximum p24 production was on average twofold lower
ompared to the control cultures (Fig. 5). These results
ndicate that nuclear transport can occur efficiently in the
bsence of Vpr and MA-NLS in G1/S phase-arrested
rimary macrophages.
onserved mutation in MA-NLS and Vpr in R7.DVpr
nd R7.DVpr.DNLS after passage through primary
acrophages
In contrast to other reports (Heinzinger et al., 1994; von
chwedler et al., 1994; Gallay et al., 1995; Bukrinsky et al.,
993), we were able to show efficient replication of
7.DVpr.DNLS in primary macrophages. To exclude that
his observation was due to the occurrence of reverting
utations in the HIV-1 genome of R7.DVpr and
7.DVpr.DNLS, we performed a sequence analysis of
FIG. 4. Analysis of proliferation and virus replication in MDM from
ncorporation at days 5, 7, 9, 12, and 14 after isolation. In parallel, M
orresponding to 1 3 103 TCID50 for Ba-L and to 1 3 10
5 TCID50 for R7.DV
nd virus replication was measured by p24 production in the culture su
8 h after inoculation by PCR analysis. For details see Material and M
FIG. 5. Replication of R7.DVpr and R7.DVpr.DNLS in growth-arrested
rimary macrophages. Five-day-cultured MDM were treated with
phidicolin (5 mg/ml) for 24 h and subsequently inoculated with an
noculum of 20 ng p24 antigen per 1 3 106 MDM, corresponding to a
irus titer of 1 3 105 TCID50 for R7.DVpr and R7.DVpr.DNLS. Virus
eplication was analyzed by measuring p24 production in the culture
upernatant. Symbols represent: replication of R7.DVpr (F,n) and
7.DVpr.DNLS (,) in untreated MDM (F,) or in aphidicolin-treated
DM (n,). The results are representative of four independent exper-
ments.resence of proviral DNA and DNA standards. *Please note that the Alu PCRp120 V3, Vpr, and gag p17. Total DNA was isolated from
irus-producing MDM cultures and subjected to PCR.
ubsequently, sequence analysis of the PCR products
as performed. The nucleotide as well as the amino acid
equence of the gp120 V3 loop was identical for all three
iruses. Both R7.DVpr and R7.DVpr.DNLS indeed pos-
essed the truncated Vpr sequence of HIV-1 HXB2 and in
he gag p17 MA protein of R7.DVpr.DNLS a lysine residue
as replaced with a threonine at positions 26 and 27.
a-L contained both a functional Vpr and a gag p17
A-NLS sequence. Interestingly, the Ba-L gag p17 MA
equence used in our study coded for a phenylalanine at
osition 132 instead of a tyrosine residue. The latter has
reviously been described to be essential for HIV-1 rep-
ication in macrophages (Gallay et al., 1995).
DISCUSSION
Previously we and others reported that a small sub-
opulation of primary macrophages is able to proliferate
n vitro (Cheung and Hamilton, 1992; Schmidtmayerova et
l., 1997; Freed et al., 1997; Schuitemaker et al., 1994;
ootstra and Schuitemaker, 1998) and that reverse tran-
cription of HIV-1 is completed only in this subpopulation
Schuitemaker et al., 1994; Kootstra and Schuitemaker,
998). Others have suggested that macrophages are
erminally differentiated and nondividing. These studies
emonstrated that compared to classical retroviruses
he presence of a functional Vpr and NLS in the MA
rotein of gag enables HIV-1 to replicate in noncycling
ells (Heinzinger et al., 1994; von Schwedler et al., 1994;
allay et al., 1995; Bukrinsky et al., 1993). Since our MDM
ulture system supports macrophage proliferation, we
redicted that the virus containing nonfunctional Vpr and
A-NLS (R7.DVpr.DNLS) (von Schwedler et al., 1994) in
ur assay would be able to establish a productive infec-
ion. Indeed, R7.DVpr.DNLS replicated efficiently in pri-
ary macrophages, as was also demonstrated by
ouchier et al. (1997). In agreement with all previous
tudies, replication of this double mutant virus was de-
endent on host cell proliferation. However, we observed
hat in nondividing cells HIV-1 replication was not dis-
urbed at the level of nuclear import, as would be ex-
ected from other studies, but at the level of reverse
ranscription, in agreement with our previous observa-
ions (Schuitemaker et al., 1994; Kootstra and Schuite-
aker, 1998). R7.DVpr, which lacks only a functional Vpr,
as been described to replicate in nondividing cells also
Bukrinsky et al., 1993; von Schwedler et al., 1994). How-
s A, B, and C (A). Cell proliferation was monitored by [3H]thymidine
ere inoculated with an inoculum of 20 ng p24 per 1 3 106 MDM,
R7.DVpr.DNLS, at days 5 (), 7 (), 9 (F), 12 (}), or 14 (n) after isolation
ant. Virus entry, reverse transcription, and integration were monitored
. (B) PCR analysis of the virus stocks and AZT-treated cultures for theDonor
DM w
pr and
pernat
ethods
is not quantitative.
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176 KOOTSTRA AND SCHUITEMAKERver, reverse transcription of this variant was also re-
tricted to the proliferating subfraction, also excluding
hat the somewhat higher p24 production relative to
7.DVpr.DNLS was due to a larger number of target cells
n the MDM cultures.
Although we have clearly demonstrated that reverse
ranscription is restricted to the cell fraction with prolif-
rative capacity, we were unable to show a correlation
etween the extent of macrophage proliferation in the
ulture and the susceptibility for HIV-1 infection. An ex-
lanation for this observation could be that the cellular
actors required for HIV-1 reverse transcription are
resent only in cycling cells but that the level of these
actors can vary, not reflecting the proliferative capacity
f the cells. This could indeed explain why in low-prolif-
rating MDM from some donors reverse transcription
nd HIV-1 infection are more efficient than in some highly
roliferating MDM from other donors. Our results are in
greement with previous reports demonstrating that
IV-1 replication in T cells, macrophages, and dendritic
ells is dependent on cell proliferation (Zack et al., 1992,
990; Schuitemaker et al., 1994; Kootstra and Schuite-
aker, 1998; Blauvelt et al., 1997). We and others have
ndeed demonstrated that the process of reverse tran-
cription is successful only in cycling cells (Zack et al.,
992, 1990; Schuitemaker et al., 1994; Kootstra and
chuitemaker, 1998) and that the actual process of mi-
osis is dispensable for the establishment of a productive
nfection since growth arrest in G1/S phase did not
nterfere with HIV-1 replication (Schuitemaker et al.,
994).
Further, we demonstrated that R7.DVpr.DNLS was able
o replicate in aphidicolin growth-arrested macrophages,
hus excluding an absolute requirement for Vpr and MA-
LS in nuclear transport of the HIV-1 preintegration com-
lex in nondividing cells, in agreement with Fouchier et
l. (1997). This observation may also indicate that other
iral proteins can provide the NLS necessary for active
uclear transport, in agreement with Gallay et al. de-
cribing a NLS function of the integrase protein (Gallay et
l., 1997).
Phosphorylation of the C-terminal tyrosine of the MA
rotein reveals the karyophilic properties and was there-
ore thought to be essential for nuclear transport of the
reintegration complex. Impaired nuclear transport of the
reintegration complex was found in macrophages when
tyrosine residue at position 132 was replaced by phe-
ylalanine (Gallay et al., 1995). Sequence analysis of the
IV-1 Ba-L, used in our study, revealed a phenylalanine
t position 132 of the MA protein. However, both in our
revious study (Kootstra and Schuitemaker, 1998) and in
he study by Freed et al. (1997), replication of viruses with
phenylalanine residue at position 132 was indistin-
uishable from that of wild-type variants with tyrosine at
osition 132.While the TCID50 of the inoculum of Ba-L was about a A00-fold lower, there were no quantitative differences in
irus entry or reverse transcription and still the overall
24 production of Ba-L was in general about 4-fold
igher compared to R7.DVpr and R7.DVpr.DNLS. Both
7.DVpr and R7.DVpr.DNLS are chimeric viruses, consist-
ng of a backbone of HIV-1HXB2, a laboratory-adapted
yncytium-inducing virus, with only a small portion of
he genome of the macrophage-tropic HIV-1 Ba-L (von
chwedler et al., 1994), which may explain their relatively
ow replication in macrophages. For syncytium-inducing
iruses we previously showed that they replicate ineffi-
iently, if at all, in primary macrophages (Schuitemaker et
l., 1991; Fouchier et al., 1994), which is determined not
nly at the level of virus entry, but also at postentry steps
Fouchier et al., 1994). Furthermore, it cannot be ex-
luded that the truncated Vpr gene of the chimeric virus
s responsible for the reduced replication in macro-
hages relative to wild-type viruses (Heinzinger et al.,
994; Westervelt et al., 1992; Malykh et al., 1995; Connor
t al., 1995; Freed et al., 1995; Popov et al., 1998).
In two previous studies the specific role of macro-
hage proliferation in HIV-1 replication was analyzed.
einberg et al. (1991) showed that g-irradiation did not
nterfere with HIV-1 infection. However, in those experi-
ents even the g-irradiated MDM still showed signifi-
ant incorporation of [3H]thymidine, indicating that suffi-
ient HIV-1-susceptible cells were left over in the culture.
chmidtmayerova et al. (1997) analyzed by in situ PCR
nd autoradiography the HIV-1-positive MDM over-
apped with MDM that had incorporated [3H]thymidine.
n that study, the number of [3H]thymidine-positive cells
as comparable to the proportion of HIV-1-positive cells.
owever, in the HIV-1-negative cultures a strongly re-
uced frequency of [3H]thymidine-positive cells was ob-
erved. These authors therefore concluded that [3H]thy-
idine incorporation was a consequence of proviral
NA synthesis. However, they do not show an overlap
etween HIV-1-positive and [3H]thymidine-positive cells.
oreover, in our system, we do not see an increase in
he proportion of BrdU-positive cells in HIV-1-infected
DM cultures.
Because of its capacity to actively migrate to the nu-
leus, HIV-1-based vectors are now under development
or transduction of noncycling cells. Transduction of neu-
al cells was, however, greatly hampered by the very low
fficiency of reverse transcription (Naldini et al., 1996)
nd transduction of retinal cells was only successful
hen cells from pups were used since these still had
roliferative capacity (Miyoshi et al., 1997). Creating the
ellular conditions essential for reverse transcription
ay therefore be of great importance in increasing the
fficiency of transduction by an HIV-1-based vector. It is
t present unclear, however, which cellular conditions
upport reverse transcription. Most likely, the increased
ucleotide pools in cycling cells facilitate this process.
ddition of dNTPs may therefore increase the efficiency
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177HIV-1 MATRIX-NLS AND Vpr FUNCTION IN MACROPHAGESf transduction. An alternative approach could be the
reincubation of the virions with dNTPs, which has in-
eed been demonstrated to support intravirion comple-
ion of reverse transcription (Zhang et al., 1996, 1993).
MATERIALS AND METHODS
solation and culture of primary macrophages
Monocytes were obtained from PBMC of HIV-1-sero-
egative blood donors by centrifugal elutriation as de-
cribed previously (Figdor et al., 1982). To obtain MDM,
onocytes were cultured at a cell concentration of 1 3
06/ml in endotoxin-free Iscove’s modified Dulbecco’s
edium (IMDM) supplemented with 10% pooled human
erum, penicillin (100 U/ml), and streptomycin (100 mg/
l) and maintained at 37°C in a humidified atmosphere
upplemented with 5% CO2. Cells were allowed to ad-
ere to plastic, thus inducing differentiation into MDM.
T–PCR demonstrated the absence of T lymphocytes in
he MDM population with primers specific for CD2 (data
ot shown).
irus
R7.DVpr and R7.DVpr.DNLS chimeras were kindly pro-
ided by Dr. D. Trono. These viruses consist of a back-
round of HIV-1HXB2 DNA with a region extending from
he distal portion of Vpr to the middle of the gp41-encod-
ng sequence of the macrophage-tropic HIV-1 Ba-L (von
chwedler et al., 1994). Both R7.DVpr and R7.DVpr.DNLS
ontain the truncated Vpr gene of HIV-1HXB2.
7.DVpr.DNLS additionally contains a nonfunctional NLS
n the gag MA protein due to lysine to threonine substi-
utions at positions 26 and 27 (MAKK27TT) (von Schwedler
t al., 1994). Infectious virus stocks were prepared by
ransfection of 239 cells with the proviral constructs
sing lipofectine. Virus stocks with high infectious titers
ere obtained after passage through phytohemaggluti-
in (PHA)-stimulated PBMC. In brief, prior to inoculation
BMC were cultured for 2 days in IMDM supplemented
ith 10% fetal calf serum (FCS), penicillin (100 U/ml),
treptomycin (100 mg/ml), PHA (1 mg/ml), and polybrene
5 mg/ml) at a concentration of 2 3 106/ml in tissue
ulture flasks. PHA-stimulated PBMC (5 3 106) were
xposed to cell free virus in a total volume of 1 ml. After
h cells were washed to remove unabsorbed virus and
ubsequently cultured in IMDM supplemented with 10%
CS, recombinant IL-2 (20 U/ml) (a generous gift from R.
ombouts, Chiron Benelux bv., Amsterdam, The Nether-
ands), polybrene (5 mg/ml), penicillin (100 U/ml), and
treptomycin (100 mg/ml) at a cell concentration of 1 3
06/ml. Virus stocks of HIV-1 Ba-L (Gartner et al., 1986)
ere generated on 5-day-cultured MDM. Infectious titers
f the virus stocks were quantified by determination of
0% tissue culture infectious doses (TCID50) in PHA-
timulated PBMC.For cell-free infection of MDM an inoculum of 20 ng
24/1 3 106 cells was used, comparable to that in other
tudies (von Schwedler et al., 1994; Gallay et al., 1995).
wenty-four hours after inoculation unabsorbed virus
as removed. Virus production was measured twice a
eek in a p24 antigen capture enzyme-linked immu-
osorbent assay (ELISA) (Tersmette et al., 1989).
nalysis of cell proliferation
To allow separation of proliferating and nonproliferat-
ng MDM, cells were incubated with BrdU (20 mM;
igma) for 48 h during inoculation. Cells were harvested
nd subsequently fixed with paraformaldehyde (2%, 10
in, 0°C) and ethanol (70%, 30 min, 0°C). DNA was
enaturated with HCl (4 N, 30 min, 0°C) and incorporated
rdU was visualized by staining with a FITC-labeled
onoclonal antibody specific for BrdU (Becton–Dickin-
on) as described previously (Schuitemaker et al., 1994).
he BrdU-negative and BrdU-positive cell fractions were
eparated by a fluorescence activated cell sorter (FACS).
To analyze the effect of g-irradiation on BrdU incorpo-
ation, 5-day cultured MDM were g-irradiated with 3000
ad prior the addition of BrdU.
For analysis of BrdU incorporation by light microscopy,
3 105 MDM were cytocentrifuged onto glass slides
nd air-dried. Slides were subsequently fixed with para-
ormaldehyde (2%, 10 min, 0°C) and ethanol (70%, 30 min,
°C), and DNA was denatured with HCl (4 N, 30 min,
°C). In addition, the slides were incubated with a mono-
lonal antibody specific for BrdU (Becton–Dickinson) and
ith a HPR-labeled goat anti-mouse immunoglobin (CLB,
M17E). BrdU incorporation was visualized by staining
ith 3-amino-9-ethyl-carbazole (AEC) (Sigma) substrate
nd poststaining with Mayer’s hemalum solution
Merck).
MDM proliferation was measured by [3H]thymidine
ncorporation. MDM were pulsed with 7.3 kBq [3H]thymi-
ine at the indicated day after isolation and harvested
fter 48 h. [3H]Thymidine incorporation was measured in
b-plate counter. MDM proliferation is quantified as low
r high when [3H]thymidine incorporation is below or
bove, respectively, 1000 cpm per 1 3 105 MDM.
NA isolation
For cell-free inoculation of MDM, virus stocks were
Nase (200 ng/ml; RQ1; Promega Corp., Madison, WI)
reated for 45 min in medium supplemented with 6 mM
gCl2 and filtered through a 0.22-mm filter. PCR analysis
f the viral inocula demonstrated the absence of proviral
NA, also excluding intravirion reverse transcription. As
n additional control for the efficacy of DNase treatment,
DM were incubated with 10 mM AZT starting 30 min
rior to inoculation, to distinguish newly synthesized
roviral DNA.Total DNA from cell fractions obtained after BrdU
s
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178 KOOTSTRA AND SCHUITEMAKERtaining and FACS sorting was isolated with QIAamp
lood kit (Qiagen). Total DNA was extracted from MDM
ultures by lysis of 1 3 106 cells in buffer L6 (Boom et al.,
991) and subsequently precipitated with isopropanol
nd washed with 70% ethanol, after which the DNA was
issolved in 100 ml water. HIV-1 DNA standards were
repared by serial dilutions of 8E5 cells, which carry a
ingle proviral DNA copy in each cell (Folks et al., 1986)
n uninfected PBMC. DNA standards for amplification of
part of the b-globin gene and integrated proviral DNA
pecies were prepared by serial dilutions of in vitro
IV-1-infected PHA-stimulated PBMC in carrier DNA.
CR analysis
For all PCR primer sets, MgCl2 concentration and
hermocycling were optimized. A two-step nested PCR
mplifying a conserved 125-bp sequence of the pol re-
ion was used to detect proviral pol DNA in DNA sam-
les obtained from the FACS-sorted cell fraction. The
IV-1 pol region was amplified in the presence of 3 mM
gCl2, and primer pair pol-D and pol-F were used in the
irst step and primer pair pol-E and pol-B were used in
he second step (Bruisten et al., 1991).
To monitor the process of reverse transcription, a
emiquantitative PCR assay amplifying the R/U5 frag-
ent, a conserved pol fragment, and the R/PBS region,
epresenting, respectively, an early, intermediate, and
ate product in reverse transcription, were used. The
IV-1 R/U5 region was amplified in the presence of 2 mM
gCl2 with primers M667/AA55 (Zack et al., 1990). To
mplify a conserved sequence of the HIV-1 pol region in
he presence of 3 mM MgCl2 primer pair pol-D and pol-F
as used (Bruisten et al., 1991). The HIV-1 R/PBS region
as amplified in the presence of 3 mM MgCl2 with
rimers M667/M661 (Zack et al., 1990). As a control for
he general efficiency of PCR amplification of the DNAs,
ll DNAs were subjected to PCR analysis in the pres-
nce of 3 mM MgCl2 with primer set PC03/PC04 ampli-
ying part of the human b-globin gene (Saiki et al., 1985).
or amplification of regions in R/U5, pol, R/PBS, and
-globin the following PCR amplification cycles were
sed: 5 min 95°C once, 1 min 30 s 95°C, 2 min 50°C, 2
in 72°C, repeated 30 times, followed by an extra 5-min
xtension at 72°C and subsequent cooling to 4°C.
To specifically detect integrated proviral DNA, a
ested PCR with primers specific for ubiquitous repeats
ound in the human genome and HIV-1 was used. This
lu HIV-1 PCR was performed in the presence of 1.5 mM
gCl2 with primer pair Alu 278 (Sonza et al., 1996) and
24-3I (Bruisten et al., 1991) in the first step and primer
air Alu 278 (Sonza et al., 1996) and M661 (Zack et al.,
990) in the second step. For amplification the following
CR amplification cycles were used: 5 min 94°C, 3 min
1°C, 5 min 72°C once, 30 s 94°C, 1 min 61°C, 5 min
2°C, repeated 35 times, followed by an extra 15-min Sxtension at 72°C and subsequent cooling to 4°C. Alu
IV-1 PCR products were detected by M667/AA55 PCR
o increase sensitivity.
To visualize positive PCR amplifications, PCR products
ere separated on 1% agarose gels, blotted on Gene-
creen membranes, and hybridized with [a-32P]dATP
nd-labeled oligonucleotide pol-C (Bruisten et al., 1991)
or pol-D/pol-F-amplified fragments, LTR-B (Fouchier et
l., 1994) for M667/AA55, M667/M661, and nested Alu
IV-1 PCR-amplified fragments and RS06 (Saiki et al.,
985) for PC03/PC04-amplified fragments. Depending on
he specific activity of the probes, autoradiography was
erformed 1–24 h at 270°C with intensifying screens.
equence analysis
For sequence analysis, gp120 V3 domains were am-
lified by PCR with primers Seq1 and Seq2 (Van’t Wout et
l., 1998) in the presence of 3 mM MgCl2 in the first
eaction and primers Seq5 and Seq6 (Van’t Wout et al.,
998) in the presence of 3 mM MgCl2 in the nested
eaction. Vpr was amplified by PCR with primers Vpr1
59-CCTTATTAGGACACATAGTTAGCCC-39, nt 5407–5431,
ense) and Vpr2 (59-TCCGCTTCTTCCTGCCATAGG-39, nt
966–5986, antisense) in the presence of 3 mM MgCl2 in
he first reaction and primers Vpr3 (59-CTCTACAATACT-
GGCACTAGCAGC-39, nt 5470–5494, sense) and Vpr4
59-GGATCTACTGGCTCCATTTCTTGC-39, nt 5823–5846,
ntisense) in the presence of 3 mM MgCl2 in the nested
eaction. gag p17 was amplified by PCR with primers
ag-1 and gag-4 (Cornelissen et al., 1995) in the pres-
nce of 2 mM MgCl2 in the first reaction and primers
ag-1 and gag-3 (Cornelissen et al., 1995) in the pres-
nce of 3 mM MgCl2 in the nested reaction. For amplifi-
ation the following PCR amplification cycles were used:
min 95°C once, 1 min 30 s 95°C, 1 min 55°C, 1 min
2°C, repeated 25 times, followed by an extra 5-min
xtension at 72°C and subsequent cooling to 4°C.
ested PCR products were purified with the QIAquick
CR purification kit (Qiagen). Dye terminator cycle se-
uencing with Ampli Taq DNA polymerase (Perkin–
lmer) was performed using the following amplification
ycles: 30 s 92°C, 15 s 50°C, 4 min 60°C, repeated 25
imes with sense or antisense nested PCR primers. Se-
uence analysis was performed on an ABI 373S auto-
ated sequencer according to the manufacturer’s proto-
ol.
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